3rd Quarter - Report — EAST END GROUP, LLC for ALVOGEN (2025)

Firm

EAST END GROUP, LLC

Client

ALVOGEN

Income

$45,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals.

Foreign entity interest: Alvogen Luxembourg SARL; Temasek Singapore

Lobbyist	Covered position, as disclosed
KELLY CHILDRESS LANGE	Rep. Shimkus, LA; Rep. Rogers, Health Policy Adviser.
ANDREW HAWKINS	Rep. Rogers, LA, Chief of Staff.

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Tariff (miscellaneous tariff bills) TAR

Section 232 investigation into pharmaceuticals and unfair trade practices.

Foreign entity interest: Alvogen Luxembourg SARL; Temasek Singapore

Lobbyist	Covered position, as disclosed
KELLY CHILDRESS LANGE	Rep. Shimkus, LA; Rep. Rogers, Health Policy Advisor

Contacted: U.S. Trade Representative (USTR); Commerce, Dept of (DOC); White House Office

Manufacturing MAN

Buy America legislation, 232 tariff investigation, regulatory incentives for domestic manufacturing.

Foreign entity interest: Alvogen Luxembourg SARL; Temasek Singapore

Lobbyist	Covered position, as disclosed
KELLY CHILDRESS LANGE	Rep. Shimkus, LA; Rep. Rogers, Health Policy Advisor

Contacted: White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.